RISLA

Class [005]
Pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system namely schizophrenia, bipolar disorders, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, cerebrovascular accident (stroke), multiple sclerosis, myasthenia gravis, Huntington's disease; pharmaceutical preparations, namely anticoagulants, anti-inflammatories and antithrombotic medicines; glycosaminoglycans, heparins and heparinoids as medicines to prevent and treat the appearance of vascular alterations; pharmaceutical preparations for the prevention and treatment of thromboembolic diseases; pharmaceutical preparations for the prevention of the recurrence of venous thrombosis in patients with deep vein thrombosis and transitory risk factors; pharmaceutical preparations for the prevention and treatment of coagulation in the extracorporeal circulation circuit during haemodialysis; pharmaceutical preparations for the prevention and treatment of diabetic foot ulcers; pharmaceutical preparations for the treatment of oncology diseases.